These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 32448615)
1. Personalized therapy and stem cell transplantation for pro-inflammatory modulation of cancer stem cells microenvironment in glioblastoma: Review. Bryukhovetskiy I; Pak O; Khotimchenko Y; Bryukhovetskiy A; Sharma A; Sharma HS Int Rev Neurobiol; 2020; 151():67-98. PubMed ID: 32448615 [TBL] [Abstract][Full Text] [Related]
2. Personalized regulation of glioblastoma cancer stem cells based on biomedical technologies: From theory to experiment (Review). Bryukhovetskiy I; Ponomarenko A; Lyakhova I; Zaitsev S; Zayats Y; Korneyko M; Eliseikina M; Mischenko P; Shevchenko V; Shanker Sharma H; Sharma A; Khotimchenko Y Int J Mol Med; 2018 Aug; 42(2):691-702. PubMed ID: 29749540 [TBL] [Abstract][Full Text] [Related]
3. Biomimetic brain tumor niche regulates glioblastoma cells towards a cancer stem cell phenotype. Liu YC; Lee IC; Chen PY J Neurooncol; 2018 May; 137(3):511-522. PubMed ID: 29357090 [TBL] [Abstract][Full Text] [Related]
4. Novel therapies hijack the blood-brain barrier to eradicate glioblastoma cancer stem cells. Vengoji R; Ponnusamy MP; Rachagani S; Mahapatra S; Batra SK; Shonka N; Macha MA Carcinogenesis; 2019 Mar; 40(1):2-14. PubMed ID: 30475990 [TBL] [Abstract][Full Text] [Related]
5. [The stem cell niche in glioblastoma: from fundamental aspects to targeted therapies]. Turpin A; Sharif A; Stoven L; Blond S; Maurage CA; Le Rhun É Bull Cancer; 2015 Jan; 102(1):24-33. PubMed ID: 25609493 [TBL] [Abstract][Full Text] [Related]
6. [Progress in the study of brain tumor stem cells as treatment targets]. Hide T; Kuratsu J Brain Nerve; 2009 Jul; 61(7):781-9. PubMed ID: 19618855 [TBL] [Abstract][Full Text] [Related]
7. Breaching barriers in glioblastoma. Part I: Molecular pathways and novel treatment approaches. Miranda A; Blanco-Prieto M; Sousa J; Pais A; Vitorino C Int J Pharm; 2017 Oct; 531(1):372-388. PubMed ID: 28755993 [TBL] [Abstract][Full Text] [Related]
8. Targeting glioblastoma cancer stem cells: the next great hope? Khan IS; Ehtesham M Neurosurg Focus; 2014 Dec; 37(6):E7. PubMed ID: 25581936 [TBL] [Abstract][Full Text] [Related]
9. Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine. Kim SS; Harford JB; Pirollo KF; Chang EH Biochem Biophys Res Commun; 2015 Dec; 468(3):485-9. PubMed ID: 26116770 [TBL] [Abstract][Full Text] [Related]
10. Glioblastoma: What can we do for these patients today and what will we be able to do in the future? Bryukhovetskiy I; Kosianova A; Zaitsev S; Pak O; Sharma A; Sharma HS Prog Brain Res; 2021; 265():99-118. PubMed ID: 34560928 [TBL] [Abstract][Full Text] [Related]
11. Brain malignancies: Glioblastoma and brain metastases. Lah TT; Novak M; Breznik B Semin Cancer Biol; 2020 Feb; 60():262-273. PubMed ID: 31654711 [TBL] [Abstract][Full Text] [Related]
12. Blockade of a Laminin-411-Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talk. Sun T; Patil R; Galstyan A; Klymyshyn D; Ding H; Chesnokova A; Cavenee WK; Furnari FB; Ljubimov VA; Shatalova ES; Wagner S; Li D; Mamelak AN; Bannykh SI; Patil CG; Rudnick JD; Hu J; Grodzinski ZB; Rekechenetskiy A; Falahatian V; Lyubimov AV; Chen YL; Leoh LS; Daniels-Wells TR; Penichet ML; Holler E; Ljubimov AV; Black KL; Ljubimova JY Cancer Res; 2019 Mar; 79(6):1239-1251. PubMed ID: 30659021 [TBL] [Abstract][Full Text] [Related]
14. Microenvironmental Modulation of Decorin and Lumican in Temozolomide-Resistant Glioblastoma and Neuroblastoma Cancer Stem-Like Cells. Farace C; Oliver JA; Melguizo C; Alvarez P; Bandiera P; Rama AR; Malaguarnera G; Ortiz R; Madeddu R; Prados J PLoS One; 2015; 10(7):e0134111. PubMed ID: 26230845 [TBL] [Abstract][Full Text] [Related]
15. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells. Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866 [TBL] [Abstract][Full Text] [Related]
16. Understanding the role of tumor stem cells in glioblastoma multiforme: a review article. Fatoo A; Nanaszko MJ; Allen BB; Mok CL; Bukanova EN; Beyene R; Moliterno JA; Boockvar JA J Neurooncol; 2011 Jul; 103(3):397-408. PubMed ID: 20853017 [TBL] [Abstract][Full Text] [Related]
17. The hypoxic peri-arteriolar glioma stem cell niche, an integrated concept of five types of niches in human glioblastoma. Aderetti DA; Hira VVV; Molenaar RJ; van Noorden CJF Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):346-354. PubMed ID: 29684521 [TBL] [Abstract][Full Text] [Related]
19. Novel cellular and post-genomic technologies in the treatment of glioblastoma multiforme (Review). Bryukhovetskiy I; Bryukhovetskiy A; Khotimchenko Y; Mischenko P Oncol Rep; 2016 Feb; 35(2):639-48. PubMed ID: 26548844 [TBL] [Abstract][Full Text] [Related]
20. Targeting cancer stem cells for treatment of glioblastoma multiforme. Cho DY; Lin SZ; Yang WK; Lee HC; Hsu DM; Lin HL; Chen CC; Liu CL; Lee WY; Ho LH Cell Transplant; 2013; 22(4):731-9. PubMed ID: 23594862 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]